Vitamin E has no role in cataract prevention

Article

Vitamin E supplements do not help to prevent cataract, according to a study published in the May 2008 issue of Ophthalmology.

Vitamin E supplements do not help to prevent cataract, according to a study published in the May 2008 issue of Ophthalmology.

William G. Christen, ScD of Brigham and Women's Hospital, Boston, US and colleagues analyzed data from the Women's Health Study (WHS), an ongoing, 10-year randomized controlled study evaluating the effects of vitamin E and low-dose aspirin in primary prevention of cardiovascular disease and cancer in apparently healthy women.

Professional women aged ≥45 years at baseline (n=39,876) took 100 mg of aspirin daily and 600 IU of vitamin E every other day for up to six and a half years. Health, lifestyle and cataract history of the women was also noted. Women taking the vitamin E supplements were found to have rates of cataract development comparable to women who did not take supplements, even amongst those women (smokers, diabetic) who would have been expected to respond well to antioxidant vitamin treatment.

Dr Christen concluded that, at least in the short-term, vitamin E supplements have no role in cataract prevention.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.